A

ACADIA Pharmaceuticals
D

ACAD

17.805
USD
-0.09
(-0.48%)
مغلق
حجم التداول
39,332
الربح لكل سهم
1
العائد الربحي
-
P/E
23
حجم السوق
2,962,607,619
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AMGN
    AMGN
    -1.26
    (-0.46%)
    273.59 USD
    BIIB
    BIIB
    1.810
    (1.28%)
    142.750 USD
    GILD
    GILD
    0.070
    (0.08%)
    93.020 USD
    JNJ
    JNJ
    -2.915
    (-1.97%)
    145.250 USD
    LLY
    LLY
    11.37
    (1.53%)
    753.86 USD
    MRK
    MRK
    -0.560
    (-0.58%)
    95.670 USD
    PFE
    PFE
    -0.621
    (-2.33%)
    26.015 USD
    المزيد
الأخبار
المقالات

العنوان: ACADIA Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.